Sexually transmitted infections (STIs) affect individuals worldwide, and several of them exhibit distinct manifestations or consequences in females. Human papillomavirus (HPV) is a prevalent STI known to cause genital warts and increase the risk of cervical cancer. Regular Pap smears and HPV vaccinations are crucial preventive measures. Chlamydia and gonorrhea, caused by bacterial infections, can lead to pelvic inflammatory disease (PID) in women if left untreated, potentially resulting in fertility issues. Regular STI screenings and antibiotic treatments are essential for managing these infections. Herpes simplex virus (HSV) is another common STI, causing genital herpes with recurring painful sores. Antiviral medications help manage symptoms and reduce transmission risk. Syphilis, caused by the bacterium Treponema pallidum, can have severe consequences if untreated, including organ damage and neurological complications. Timely diagnosis and antibiotic therapy are critical for preventing long-term health issues. Comprehensive sexual health education, regular screenings, and the promotion of safe sexual practices are vital components in the prevention and management of female STIs. Public health initiatives also play a key role in reducing the prevalence and impact of these infections.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation